Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Immunity. 2011 May 27;34(5):680-92. doi: 10.1016/j.immuni.2011.05.003.

    Immune signaling by RIG-I-like receptors.

    Source

    Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195-7650, USA.

    Abstract

    The RIG-I-like receptors (RLRs) RIG-I, MDA5, and LGP2 play a major role in pathogen sensing of RNA virus infection to initiate and modulate antiviral immunity. The RLRs detect viral RNA ligands or processed self RNA in the cytoplasm to trigger innate immunity and inflammation and to impart gene expression that serves to control infection. Importantly, RLRs cooperate in signaling crosstalk networks with Toll-like receptors and other factors to impart innate immunity and to modulate the adaptive immune response. RLR regulation occurs at a variety of levels ranging from autoregulation to ligand and cofactor interactions and posttranslational modifications. Abberant RLR signaling or dysregulation of RLR expression is now implicated in the development of autoimmune diseases. Understanding the processes of RLR signaling and response will provide insights to guide RLR-targeted therapeutics for antiviral and immune-modifying applications.

    Copyright © 2011 Elsevier Inc. All rights reserved.

    PMID:
    21616437
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3177755
    Free PMC Article

    Images from this publication.See all images (2)Free text

    Figure 2
    Figure 1

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk